NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromes
Relapse has become the major cause of treatment failure after allogeneic stem cell transplantation. Outcome of patients with clinical relapse after transplantation generally remains poor, but intervention prior to florid relapse improves outcome for certain hematologic malignancies. To detect early...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 June 2010
|
| In: |
Biology of blood and marrow transplantation
Year: 2010, Jahrgang: 16, Heft: 9, Pages: 1187-1211 |
| ISSN: | 1523-6536 |
| DOI: | 10.1016/j.bbmt.2010.06.008 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bbmt.2010.06.008 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1083879110002521 
|
| Verfasserangaben: | Nicolaus Kröger, Ulrike Bacher, Peter Bader, Sebastian Böttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, Homer Macapintac, Eduardo Olavarria, Jerald Radich, Wendy Stock, Julie M. Vose, Daniel Weisdorf, Andre Willasch, Sergio Giralt, Michael R. Bishop, Alan S. Wayne |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1838199675 | ||
| 003 | DE-627 | ||
| 005 | 20250415000200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230306s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbmt.2010.06.008 |2 doi | |
| 035 | |a (DE-627)1838199675 | ||
| 035 | |a (DE-599)KXP1838199675 | ||
| 035 | |a (OCoLC)1389821331 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kröger, Nicolaus |d 1959- |e VerfasserIn |0 (DE-588)112156533 |0 (DE-627)477107354 |0 (DE-576)167115103 |4 aut | |
| 245 | 1 | 0 | |a NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation |b report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromes |c Nicolaus Kröger, Ulrike Bacher, Peter Bader, Sebastian Böttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, Homer Macapintac, Eduardo Olavarria, Jerald Radich, Wendy Stock, Julie M. Vose, Daniel Weisdorf, Andre Willasch, Sergio Giralt, Michael R. Bishop, Alan S. Wayne |
| 264 | 1 | |c 14 June 2010 | |
| 300 | |a 25 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.03.2023 | ||
| 520 | |a Relapse has become the major cause of treatment failure after allogeneic stem cell transplantation. Outcome of patients with clinical relapse after transplantation generally remains poor, but intervention prior to florid relapse improves outcome for certain hematologic malignancies. To detect early relapse or minimal residual disease, sensitive methods such as molecular genetics, tumor-specific molecular primers, fluorescein in situ hybridization, and multiparameter flow cytometry (MFC) are commonly used after allogeneic stem cell transplantation to monitor patients, but not all of them are included in the commonly employed disease-specific response criteria. The highest sensitivity and specificity can be achieved by molecular monitoring of tumor- or patient-specific markers measured by polymerase chain reaction-based techniques, but not all diseases have such targets for monitoring. Similar high sensitivity can be achieved by determination of donor chimerism, but its specificity regarding detection of relapse is low and differs substantially among diseases. Here, we summarize the current knowledge about the utilization of such sensitive monitoring techniques based on tumor-specific markers and donor cell chimerism and how these methods might augment the standard definitions of posttransplant remission, persistence, progression, relapse, and the prediction of relapse. Critically important is the need for standardization of the different residual disease techniques and to assess the clinical relevance of minimal residual disease and chimerism surveillance in individual diseases, which in turn, must be followed by studies to assess the potential impact of specific interventional strategies. | ||
| 650 | 4 | |a Acute leukemia | |
| 650 | 4 | |a Allogeneic stem cell transplantation | |
| 650 | 4 | |a Chimerism | |
| 650 | 4 | |a Minimal residual disease | |
| 650 | 4 | |a Myelodysplastic syndrome | |
| 700 | 1 | |8 1\p |a Bacher, Ulrike |d 1970- |e VerfasserIn |0 (DE-588)122079183 |0 (DE-627)081723822 |0 (DE-576)182565335 |4 aut | |
| 700 | 1 | |a Bader, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Böttcher, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Borowitz, Michael J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Khouri, Issa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Macapintac, Homer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Olavarria, Eduardo |e VerfasserIn |4 aut | |
| 700 | 1 | |8 2\p |a Radich, Jerald P. |e VerfasserIn |0 (DE-588)139087923 |0 (DE-627)608113182 |0 (DE-576)31020402X |4 aut | |
| 700 | 1 | |a Stock, Wendy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vose, Julie M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weisdorf, Daniel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Willasch, Andre |e VerfasserIn |4 aut | |
| 700 | 1 | |a Giralt, Sergio |e VerfasserIn |4 aut | |
| 700 | 1 | |8 3\p |a Bishop, Michael R. |e VerfasserIn |0 (DE-588)1057861723 |0 (DE-627)795344198 |0 (DE-576)294269975 |4 aut | |
| 700 | 1 | |a Wayne, Alan S. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biology of blood and marrow transplantation |d [Erscheinungsort nicht ermittelbar] : Elsevier Health Sciences, 1998 |g 16(2010), 9 vom: Juni, Seite 1187-1211 |h Online-Ressource |w (DE-627)334374782 |w (DE-600)2057605-5 |w (DE-576)118352229 |x 1523-6536 |7 nnas |a NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromes |
| 773 | 1 | 8 | |g volume:16 |g year:2010 |g number:9 |g month:06 |g pages:1187-1211 |g extent:25 |a NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromes |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bbmt.2010.06.008 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1083879110002521 |x Verlag |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250403 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20230306 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 999 | |a KXP-PPN1838199675 |e 4283616400 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Kröger, Nicolaus","family":"Kröger","given":"Nicolaus","role":"aut"},{"role":"aut","display":"Bacher, Ulrike","family":"Bacher","given":"Ulrike"},{"role":"aut","given":"Peter","display":"Bader, Peter","family":"Bader"},{"display":"Böttcher, Sebastian","family":"Böttcher","given":"Sebastian","role":"aut"},{"display":"Borowitz, Michael J.","family":"Borowitz","given":"Michael J.","role":"aut"},{"given":"Peter","family":"Dreger","display":"Dreger, Peter","role":"aut"},{"role":"aut","display":"Khouri, Issa","family":"Khouri","given":"Issa"},{"family":"Macapintac","display":"Macapintac, Homer","given":"Homer","role":"aut"},{"role":"aut","given":"Eduardo","family":"Olavarria","display":"Olavarria, Eduardo"},{"given":"Jerald P.","display":"Radich, Jerald P.","family":"Radich","role":"aut"},{"given":"Wendy","display":"Stock, Wendy","family":"Stock","role":"aut"},{"role":"aut","display":"Vose, Julie M.","family":"Vose","given":"Julie M."},{"role":"aut","given":"Daniel","display":"Weisdorf, Daniel","family":"Weisdorf"},{"given":"Andre","display":"Willasch, Andre","family":"Willasch","role":"aut"},{"role":"aut","given":"Sergio","family":"Giralt","display":"Giralt, Sergio"},{"given":"Michael R.","display":"Bishop, Michael R.","family":"Bishop","role":"aut"},{"family":"Wayne","display":"Wayne, Alan S.","given":"Alan S.","role":"aut"}],"title":[{"subtitle":"report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromes","title":"NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation","title_sort":"NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation"}],"physDesc":[{"extent":"25 S."}],"relHost":[{"part":{"year":"2010","extent":"25","issue":"9","volume":"16","pages":"1187-1211","text":"16(2010), 9 vom: Juni, Seite 1187-1211"},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"BBMT"}],"title":[{"title":"Biology of blood and marrow transplantation","subtitle":"BBMT ; the official journal of the American Society for Blood and Marrow Transplantation","title_sort":"Biology of blood and marrow transplantation"}],"language":["eng"],"id":{"eki":["334374782"],"issn":["1523-6536"],"zdb":["2057605-5"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Elsevier Health Sciences ; Carden Jennings","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Charlottesville, Va.","dateIssuedDisp":"[1998-2020]"}],"pubHistory":["Volume 4, issue 1 (June 1998)-Volume 26, issue 12 (December 2020)"],"note":["Gesehen am 16.03.2021"],"recId":"334374782","disp":"NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. part I: methods, acute leukemias, and myelodysplastic syndromesBiology of blood and marrow transplantation"}],"id":{"doi":["10.1016/j.bbmt.2010.06.008"],"eki":["1838199675"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"origin":[{"dateIssuedDisp":"14 June 2010","dateIssuedKey":"2010"}],"name":{"displayForm":["Nicolaus Kröger, Ulrike Bacher, Peter Bader, Sebastian Böttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, Homer Macapintac, Eduardo Olavarria, Jerald Radich, Wendy Stock, Julie M. Vose, Daniel Weisdorf, Andre Willasch, Sergio Giralt, Michael R. Bishop, Alan S. Wayne"]},"recId":"1838199675","note":["Gesehen am 06.03.2023"]} | ||
| SRT | |a KROEGERNICNCIFIRSTIN1420 | ||